The predominant targets in NSCLC are cytotoxic T lymphocyte-associated protein 4 (CTLA-4), programmed death receptor 1 (PD-1), and programmed death ligand 1 (PD-L1) (4). Here, CD274 is linked to non-small cell lung carcinoma.